Healthcare Infection Control Practices Advisory Committee (HICPAC): Meeting, 27817 [E7-9479]
Download as PDF
<![CDATA[
Federal Register / Vol. 72, No. 95 / Thursday, May 17, 2007 / Notices
NIEHS under NICEATM. NICEATM
administers ICCVAM and provides
scientific and operational support for
ICCVAM-related activities. NICEATM
and ICCVAM work collaboratively to
evaluate new and improved test
methods applicable to the needs of
federal agencies. Additional information
about ICCVAM and NICEATM is
available on the following Web site:
https://iccvam.niehs.nih.gov.
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 8, 2007.
David A. Schwartz,
Director, National Institute of Environmental
Health Sciences and National Toxicology
Program.
[FR Doc. E7–9544 Filed 5–16–07; 8:45 am]
BILLING CODE 4163–18–P
Dated: May 10, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–9498 Filed 5–16–07; 8:45 am]
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Healthcare Infection Control Practices
Advisory Committee (HICPAC):
Meeting
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Evaluation of
Vaccination Reminder/Recall Systems
for Adolescent Patients, Funding
Opportunity Announcement (FOA)
IP07–007, Strategies to Reach the
‘‘Unreachable’’ Through Immunization
Registries, FOA IP07–010, and Using
Provider Reminder/Recall to Enhance
Up-to-Date Coverage of 18-Month Olds,
FOA IP07–012
pwalker on PROD1PC71 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Time and Date: 12 p.m.–4 p.m., June 18,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of research grant applications in
response to FOA IP07–007, ‘‘Evaluation of
Vaccination Reminder/Recall Systems for
Adolescent Patients,’’ FOA IP07–010,
‘‘Strategies to Reach the ‘‘Unreachable’’
Through Immunization Registries,’’ and FOA
IP07–012, ‘‘Using Provider Reminder/Recall
to Enhance Up-to-Date Coverage of 18-Month
Olds.’’
For Further Information Contact: Trudy
Messmer, Ph.D., Designated Federal Official,
1600 Clifton Road, Mailstop C–19, Atlanta,
GA 30333, telephone (404) 639–3770.
The Director, Management Analysis and
Services Office, has been delegated the
VerDate Aug<31>2005
17:15 May 16, 2007
Jkt 211001
Dated: May 10, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–9479 Filed 5–16–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
Centers for Disease Control and
Prevention
27817
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Times and Dates: 8:30 a.m.–5 p.m., June
11, 2007. 8:30 a.m.–3 p.m., June 12, 2007.
Place: CDC Roybal Campus, Bldg 19,
Auditorium B3, 1600 Clifton Road, NE.,
Atlanta, GA 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, the Assistant Secretary for Health,
the Director, CDC, and the Director, National
Center for Infectious Diseases (NCID),
regarding (1) the practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters to be Discussed: Agenda items will
include: Guideline Planning, Discussion of
Norovirus Guideline, Discussion of Urinary
Track Infection Guideline, Healthcare
Infection Control Information Technology
follow up and Surveillance Definitions
discussion.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Angela B. Scott, Committee Management
Specialist, HICPAC, Division of Healthcare
Quality Promotion, NCID, CDC, l600 Clifton
Road, NE., M/S A–07, Atlanta, GA 30333,
telephone 404/639–1526.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
Proposed Collection; Comment
Request; Physicians’ Experience of
Ethical Dilemmas and Resource
Allocation
SUMMARY: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute of Dental and
Craniofacial Research (NIDCR), the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection
Title: Physicians’ Experience of
Ethical Dilemmas and Resource
Allocation.
Type of Information Collection
Request: New.
Need and Use of Information
Collection: Health care costs are rising
ceaselessly and there are currently no
generally accepted way of controlling
them. This study will access the
experience of physicians regarding
resource allocation in clinical practice,
and how allocation decisions made at
other levels shapes this experience. The
primary objectives of the study are to
determine if physicians make decisions
to withhold interventions on the basis of
cost, how often they report doing so,
what types of care are withheld, and
what criteria are used in making such
decisions. The findings will provide
valuable information concerning: (1)
The practice of resource allocation in
clinical practice, (2) the possible effects
of perceived constraints on this practice,
and (3) international comparisons on
these two aspects.
Frequency of Response: Once.
Affected Public: Individuals or
households; Businesses or other forprofit; Not-for-profit institutions.
Type of Respondents: Physicians.
E:\FR\FM\17MYN1.SGM
17MYN1
]]>Agencies
[Federal Register Volume 72, Number 95 (Thursday, May 17, 2007)]
[Notices]
[Page 27817]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-9479]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC): Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Times and Dates: 8:30 a.m.-5 p.m., June 11, 2007. 8:30 a.m.-3
p.m., June 12, 2007.
Place: CDC Roybal Campus, Bldg 19, Auditorium B3, 1600 Clifton
Road, NE., Atlanta, GA 30333.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with providing advice and
guidance to the Secretary, the Assistant Secretary for Health, the
Director, CDC, and the Director, National Center for Infectious
Diseases (NCID), regarding (1) the practice of hospital infection
control; (2) strategies for surveillance, prevention, and control of
infections (e.g., nosocomial infections), antimicrobial resistance,
and related events in settings where healthcare is provided; and (3)
periodic updating of guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters to be Discussed: Agenda items will include: Guideline
Planning, Discussion of Norovirus Guideline, Discussion of Urinary
Track Infection Guideline, Healthcare Infection Control Information
Technology follow up and Surveillance Definitions discussion.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Angela B. Scott, Committee
Management Specialist, HICPAC, Division of Healthcare Quality
Promotion, NCID, CDC, l600 Clifton Road, NE., M/S A-07, Atlanta, GA
30333, telephone 404/639-1526.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: May 10, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-9479 Filed 5-16-07; 8:45 am]
BILLING CODE 4163-18-P
